SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-004232
Filing Date
2024-03-04
Accepted
2024-03-04 19:52:22
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5428
  Complete submission text file 0001209191-24-004232.txt   6903
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, STE 250 SAN DIEGO CA 92130
Business Address
Mancini Marianna (Reporting) CIK: 0001838112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 24717687